Biomarker ID | 1699 |
PMID | 26126436 |
Year | 2015 |
Biomarker | hsa-miR-16 |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Urine |
Subjects | Humans |
Regulation | Upregulated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathway include: RNA binding; nucleus; nucleoplasm; protein-containing complex; ribonucleoprotein complex |
Experiment | Prostate Cancer Vs Benign prostatic hyperplasia |
Type of Biomarker | Diagnostic |
Cohort | For discovery cohort, 48 Benign Prostatic Hyperplaisa BPH) patients with 70 PCa patients were considered. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.04 |
Method Used | qRT-PCR |
Clinical | No |
Remarks | Values in regulatation column are presented as median (interquartile range; × 102 copies/miRNA concentration) |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |